Update on Prevalence of Pain in Patients with Cancer 2022: A Systematic Literature Review and Meta-Analysis

R.A.H. Snijders*, L. Brom, M. Theunissen, M.H.J.V. Everdingen

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

Abstract

Simple Summary Pain associated with cancer diagnoses is a serious concern and one of the most common symptoms reported by cancer patients. The insufficient relief of cancer pain can have a major impact on patients' quality of life. Recent developments in oncology such as new pain management guidelines, drugs and treatment strategies may have had a positive effect on the prevalence and severity of pain. Therefore, the aim of this systematic literature review was to assess the prevalence of pain and pain severity in cancer patients throughout all phases of treatment in the 2014-2021 literature period. Our results show a decline in both the prevalence and severity of cancer pain, compared to previous research. Nevertheless, with 44.5% of cancer patients still experiencing pain, the prevalence remains high, emphasizing the need for ongoing attention regarding the management of cancer pain. Experiencing pain and insufficient relief can be devastating and negatively affect a patient's quality of life. Developments in oncology such as new treatments and adjusted pain management guidelines may have influenced the prevalence of cancer pain and severity in patients. This review aims to provide an overview of the prevalence and severity of pain in cancer patients in the 2014-2021 literature period. A systematic literature search was performed using the databases PubMed, Embase, CINAHL, and Cochrane. Titles and abstracts were screened, and full texts were evaluated and assessed on methodological quality. A meta-analysis was performed on the pooled prevalence and severity rates. A meta-regression analysis was used to explore differences between treatment groups. We identified 10,637 studies, of which 444 studies were included. The overall prevalence of pain was 44.5%. Moderate to severe pain was experienced by 30.6% of the patients, a lower proportion compared to previous research. Pain experienced by cancer survivors was significantly lower compared to most treatment groups. Our results imply that both the prevalence of pain and pain severity declined in the past decade. Increased attention to the assessment and management of pain might have fostered the decline in the prevalence and severity of pain.
Original languageEnglish
Article number591
Number of pages39
JournalCancers
Volume15
Issue number3
DOIs
Publication statusPublished - 1 Feb 2023

Keywords

  • cancer pain
  • prevalence
  • systematic review
  • meta-analysis
  • meta-regression
  • QUALITY-OF-LIFE
  • SUPPORTIVE CARE NEEDS
  • CELL LUNG-CANCER
  • ASSISTED LAPAROSCOPIC HYSTERECTOMY
  • CHRONIC POSTOPERATIVE PAIN
  • SYMPTOM ASSESSMENT SCALE
  • NURSING-HOME RESIDENTS
  • BREAST-CANCER
  • RISK-FACTORS
  • REPORTED OUTCOMES

Fingerprint

Dive into the research topics of 'Update on Prevalence of Pain in Patients with Cancer 2022: A Systematic Literature Review and Meta-Analysis'. Together they form a unique fingerprint.

Cite this